Robert Krause

9.3k citations
173 papers · 5.7k · 1 hit paper · h-index 41

Impact in

Papers in

    • Antifungal resistance and susceptibility 58
    • Clostridium difficile and Clostridium perfringens research 12
    • Fungal Infections and Studies 37
    • Pneumocystis jirovecii pneumonia detection and treatment 13
    • Sepsis Diagnosis and Treatment 9
    • Pneumonia and Respiratory Infections 7

Robert Krause

166 papers receiving 5.5k citations

Robert Krause's Hit Papers

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin 2021 · 306 citations
3060+1+3Years since publication100200300

Peers

Robert Krause
Comparison fields: 5 of 140
  • Infectious Diseases 3.0k
  • Applied Microbiology and Biotechnology 148
  • Epidemiology 2.3k
  • Molecular Medicine 264
  • Microbiology 321
Replace Koichi Izumikawa with:
Koichi Izumikawa Japan
Heungsup Sung South Korea
Thomas R. Rogers United Kingdom
Annelies Verbon Netherlands
Martin Hoenigl Austria
Sang‐Oh Lee South Korea
Peter Speelman Netherlands
Jun Hee Woo South Korea
Katsunori Yanagihara Japan
J. A. A. Hoogkamp‐Korstanje Netherlands
Robert Krause relative to Koichi Izumikawa Japan Koichi Izumikawa's profile →
Citations per field
00.5×1.6×
Koichi Izumikawa · 1×
Citations per year

Countries citing papers authored by Robert Krause

Since Specialization
Citations

This map shows the geographic impact of Robert Krause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Krause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Krause more than expected).

Fields of papers citing papers by Robert Krause

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Krause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Krause. The network helps show where Robert Krause may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Krause, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Krause Line = papers co-authored together Robert Krause links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000370
2
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Hit paper breakdown →
2021306
3 2020284
4 2003259
5 2006250
6 2014188
7 2016113
8 2019107
9 2014106
10 2014105
11 2021101
12 200085
13 201880
14 201080
15 200178
16 201676
17 202174
18 202170
19 201570
20 201370

About Robert Krause

Robert Krause is a scholar working on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Clinical Biochemistry and Molecular Biology, having authored 173 papers that have together received 5.7k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (58 papers), Fungal Infections and Studies (37 papers), Bacterial Identification and Susceptibility Testing (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Clostridium difficile and Clostridium perfringens research (12 papers), Sepsis Diagnosis and Treatment (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Pneumonia and Respiratory Infections (7 papers). The work is most often cited by research in Infectious Diseases (3.0k citations), Applied Microbiology and Biotechnology (148 citations), Epidemiology (2.3k citations), Molecular Medicine (264 citations) and Microbiology (321 citations). Robert Krause has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Martin Hoenigl, Christoph Wenisch, Ines Zollner‐Schwetz, Juergen Prattes, Florian Daxboeck, Reinhard B. Raggam, Cornelia Lass‐Flörl, Sanda Patruta, Walter H. Hörl and Thomas Valentin. Their work appears in journals such as Mycoses, Clinical Microbiology and Infection, Journal of Clinical Microbiology, Journal of Fungi and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact